A Science-Driven Approach to Capital Growth
We invest across the capital structure in both public and private companies within healthcare. From early-stage biotech breakthroughs to established medical device leaders, our disciplined process evaluates unmet medical needs, IP strength, clinical/regulatory trajectory, and commercial scalability.
Target Sectors
We focus our investments across four key healthcare sectors where innovation drives the greatest potential for transformative patient outcomes and superior returns.
Biotechnology & Biopharma
Innovative therapeutics, gene therapies, and breakthrough drug development platforms transforming patient outcomes.
Medical Devices & Diagnostics
Next-generation medical devices, precision diagnostics, and surgical technologies improving healthcare delivery.
Digital Health & AI-Enabled Tools
Cutting-edge healthcare software, AI-powered diagnostics, and digital therapeutics revolutionizing care delivery.
Healthcare Services & Platforms
Scalable healthcare service models, care coordination platforms, and innovative delivery mechanisms.
Stage Focus
Our investment strategy spans multiple stages of company development, from early-stage ventures to established public companies, providing flexible capital solutions across the healthcare ecosystem.
Venture & Pre-IPO
Early-stage investments in breakthrough technologies and companies preparing for public markets, focusing on high-growth potential and transformative innovations.
Small to Mid-Cap Public Equities
Strategic investments in established public companies with strong fundamentals, proven business models, and significant growth runway in healthcare markets.
Opportunistic Private Credit & Structured Equity
Flexible capital solutions including debt financing, structured products, and hybrid instruments for companies requiring specialized funding approaches.